Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06175000 |
| Title | Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Providence Health & Services |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Providence St. Vincent Medical Center | RECRUITING | Portland | Oregon | 97225 | United States | Details |
| Pennsylvania State University | RECRUITING | Hershey | Pennsylvania | 17033 | United States | Details |
| University of Vermont | RECRUITING | Burlington | Vermont | 05405 | United States | Details |
| Ivy Center for Advanced Brain Tumor Treatment; Swedish Neuroscience Institute | NOT_YET_RECRUITING | Seattle | Washington | 98122 | United States | Details |